FDA Rejects J&J Petition, OKs Duragesic Generics

Law360 (January 31, 2005, 12:00 AM EST) -- The U.S. Food and Drug Administration has rejected petitions to block or delay the approval of generic versions of the Duragesic pain relief patch made by Johnson & Johnson.

Generic drug makers Mylan Laboratories Inc. and Noven Pharmaceuticals received approval for their generic version of Duragesic on Friday.

“The agency's approval is expected to provide patients with access to a lower cost alternative of this pain management system. At the same time that FDA approved Mylan's generic product, it acted on several citizens' petitions requesting that...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.